Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (73 total)
-
Créateur: Verity, Robert, Lucy C. Okell, Ilaria Dorigatti, Peter Winskill, Charles Whittaker, Natsuko Imai, Gina Cuomo-Dannenburg, Hayley Thompson, Patrick G. T. Walker, Han Fu, Amy Dighe, Jamie T. Griffin, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri,…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-30
Description: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. -
Créateur: University of Nebraska Medical Center / Nebraska Medicine
Sujet: General
Type d'élément: Webinaire
Date de la dernière mise à jour: 2018-01-08
Description: Resources - National Ebola Training and Education CenterExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: the Siren Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-09
Description: Increased understanding of whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to investigate whether antibodies against SARS-CoV-2 were associated with a decreased… -
Créateur: the Oxford University Hospitals Staff Testing Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-11
Description: The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: the Oxford COVID-19 Vaccine Trial Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-30
Description: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this variant. -
Créateur: the Overcoming COVID-19 Investigators
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-06-16
Description: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. -
Créateur: the mRNA-1273 Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-06
Description: Interim results from a phase 3 trial of the Moderna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine indicated 94% efficacy in preventing coronavirus disease 2019 (Covid-19). -
Créateur: The Medical Letter on Drugs and Therapeutics
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Créateur: the GS-US-540-5773 Investigators
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-11-05
Description: We conducted a randomized, open-label, phase 3 trial involving hospitalized patients with confirmed SARS-CoV-2 infection, oxygen saturation of 94% or less while they were breathing ambient air, and radiologic evidence of pneumonia. -
Créateur: the COVID-19 Genomics UK (COG-UK) consortium
Sujet: Personnel Management
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-27
Description: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. It is suspected that the delta variant is associated with more severe disease…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.